PREDICTING FAVOURABLE PATHOLOGICAL OUTCOME IN PATIENTS WITH CLINICAL HIGH RISK PROSTATE CANCER. A NOVEL NOMOGRAM BASED ON A MULTI-INSTITUTIONAL ANALYSIS

被引：0
|
作者：
Briganti, Alberto
Spahn, Martin
Joniau, Steven
Gontero, Paolo
Montorsi, Francesco
Marchioro, Giansilvio
Tombal, Bertrand
Frohneberg, Detlef
Isbarn, Hendrik
Bangma, Chris
Schroeder, Fritz
Kneitz, Burkhard
Bader, Pia
Graefen, Markus
Tizzani, Alessandro
Van Poppel, Hendrik
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 04期
关键词：
D O I：
10.1016/j.juro.2010.02.1317
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1552
引用
收藏
页码：E599 / E599
页数：1
相关论文
共 50 条
  • [1] PREDICTING FAVOURABLE PATHOLOGICAL OUTCOME IN PATIENTS WITH CLINICAL HIGH RISK PROSTATE CANCER. A NOVEL NOMOGRAM BASED ON A MULTI-INSTITUTIONAL ANALYSIS
    Briganti, A.
    Spahn, M.
    Joniau, S.
    Gontero, P.
    Montorsi, F.
    Marchioro, G.
    Tombal, B.
    Frohneberg, D.
    Isbarn, H.
    Bangma, C. H.
    Schroder, F. H.
    Kneitz, B.
    Bader, P.
    Graefen, M.
    Tizzani, A.
    Van Poppel, H.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 317 - 318
  • [2] TREATMENT INTENSIFICATION AND OUTCOME IN HIGH-RISK PROSTATE CANCER:A MULTI-INSTITUTIONAL CONSORTIUM ANALYSIS
    Kishan, Amar
    Karnes, R. Jeffrey
    Romero, Tahmineh
    Motterle, Giovanni
    Tendulkar, Rahul
    Klein, Eric
    Wong, J. Karen
    Horwitz, Eric
    Tward, Jonathan
    Dess, Robert
    Wedde, Trude
    Lilleby, Wolfgang
    Merrick, Gregory
    Stock, Richard
    Krauss, Daniel
    Phuoc Tran
    Moran, Brian
    Spratt, Daniel
    Stish, Bradley
    Davis, Brian
    Levin-Epstein, Rebecca
    Reddy, Chandana
    Stephenson, Andrew
    Braccioforte, Michelle
    Fiano, Ryan
    King, Christopher
    Rettig, Matt
    Steinberg, Michael
    Nickols, Nicholas
    Elashoff, David
    Demanes, D. Jeffrey
    Reiter, Robert
    Tilki, Derya
    JOURNAL OF UROLOGY, 2020, 203 : E1293 - E1293
  • [3] Development and validation of a novel nomogram predicting clinically significant prostate cancer in biopsy-naive men based on multi-institutional analysis
    Ge, Qingyu
    Zhang, Sicong
    Xu, Hewei
    Zhang, Junjie
    Fan, Zongyao
    Li, Weilong
    Shen, Deyun
    Xiao, Jun
    Wei, Zhongqing
    CANCER MEDICINE, 2023, 12 (24): : 21820 - 21829
  • [4] Multi-institutional Outcome Following LDR Brachytherapy in Patients with Higher Risk Prostate Cancer
    Conroy, R.
    Hoskin, P.
    Bottomley, D.
    Mandall, P.
    Swindell, R.
    Wylie, J.
    CLINICAL ONCOLOGY, 2012, 24 (02) : 155 - 155
  • [5] Development and validation of a multi-institutional nomogram of outcomes for PSMA-PET-based salvage radiotherapy in recurrent prostate cancer.
    Zamboglou, Constantinos
    Arnoux, Armelle
    Janbain, Ali
    Strouthos, Iosif
    Farolfi, Andrea
    Koerber, Stefan
    Peeken, Jan
    Vogel, Marco
    Ferentinos, Konstantinos
    Shelan, Mohamed
    Grosu, Anca L.
    Kroeze, Stephanie
    Guckenberger, Matthias
    Fanti, Stefano
    Hruby, George
    Scharl, Sophia
    Wiegel, Thomas
    Henkeberens, Christoph
    Emmett, Louise
    Hegemann, Nina-Sophie
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [6] DEVELOPMENT AND INTERNAL VALIDATION OF NOMOGRAMS PREDICTING PROSTATE CANCER SPECIFIC SURVIVAL IN PATIENTS WITH HIGH RISK DISEASE. RESULTS OF A MULTI-INSTITUTIONAL ANALYSIS
    Briganti, Alberto
    Spahn, Martin
    Joniau, Steven
    Gontero, Paolo
    Marchioro, Giansilvio
    Tombal, Bertrand
    Hsu, Chao-Yu
    Bader, Pia
    Graefen, Markus
    Tizzani, Alessandro
    Van Cangh, Paul
    Montorsi, Francesco
    Van Poppel, Hein
    JOURNAL OF UROLOGY, 2011, 185 (04): : E284 - E284
  • [7] DEVELOPMENT AND INTERNAL VALIDATION OF NOMOGRAMS PREDICTING PROSTATE CANCER SPECIFIC SURVIVAL IN PATIENTS WITH HIGH RISK DISEASE. RESULTS OF A MULTI-INSTITUTIONAL ANALYSIS
    Briganti, A.
    Spahn, M.
    Joniau, S.
    Marchioro, G.
    Tombal, B.
    Hsu, H.
    Bader, P.
    Graefen, M.
    Tizzani, A.
    Van Cangh, P.
    Gontero, P.
    Van Poppel, H.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 324 - 324
  • [8] Multi-institutional analysis of high-risk prostate cancer patients treated with stereotactic body radiotherapy.
    Jiang, Naomi Y.
    King, Christopher R.
    Katz, Alan J.
    Collins, Sean P.
    Aghdam, Nima
    Suy, Simeng
    Stephans, Kevin L.
    Reddy, Chandana A.
    Kaplan, Irving D.
    Appelbaum, Limor
    Dang, Audrey
    Yuan, Ye
    Nickols, Nicholas George
    Steinberg, Michael L.
    Kupelian, Patrick
    Kishan, Amar Upadhyaya
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [9] Multi-institutional nomogram for PSMA-PET based salvage radiotherapy in recurrent prostate cancer
    Zamboglou, C.
    Ferentinos, K.
    Arnoux, A.
    Janbain, A.
    Strouthose, I.
    Farolfi, A.
    Koerber, S. A.
    Peeken, J. C.
    Vogel, M.
    Vrachimis, A.
    Spohn, S. K. B.
    Shelan, M.
    Grosu, A.
    Kroeze, S.
    Guckenberger, M.
    Fanti, S. F.
    Belka, C.
    Hruby, G.
    Scharl, S.
    Wiegel, T.
    Henkenberens, C.
    Emmett, L.
    Schmidt-Hegemann, N. S.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S335 - S336
  • [10] External evaluation of the Briganti nomogram predicting lymph node invasion in patients with very-low to high risk prostate cancer: A retrospective multi-institutional cohort study in Japan
    Sugihara, Naoya
    Hashine, Katsuyoshi
    Yamashita, Natsumi
    Tachou, Takatoshi
    Kan, Masaharu
    Oka, Akihiro
    Takeda, Hajime
    Miura, Noriyoshi
    Miyauchi, Yuki
    Saika, Takashi
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 : 154 - 154
12345